Nanalysis Scientific Past Earnings Performance
Past criteria checks 0/6
Nanalysis Scientific's earnings have been declining at an average annual rate of -58.1%, while the Medical Equipment industry saw earnings growing at 11.9% annually. Revenues have been growing at an average rate of 30% per year.
Key information
-58.1%
Earnings growth rate
-47.9%
EPS growth rate
| Medical Equipment Industry Growth | -19.2% |
| Revenue growth rate | 30.0% |
| Return on equity | -71.5% |
| Net Margin | -56.9% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Benign Growth For Nanalysis Scientific Corp. (CVE:NSCI) Underpins Stock's 25% Plummet
Mar 24
Nanalysis Scientific Corp. (CVE:NSCI) Shares Fly 43% But Investors Aren't Buying For Growth
Feb 08We Think Nanalysis Scientific (CVE:NSCI) Has A Fair Chunk Of Debt
Jan 31Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?
Aug 26Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking
Apr 17Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?
Dec 08Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?
Jul 15Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?
Jan 24Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?
Mar 29Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?
Dec 14
Revenue & Expenses BreakdownBeta
How Nanalysis Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 28 | -16 | 12 | 1 |
| 30 Sep 23 | 26 | -17 | 14 | 1 |
| 30 Jun 23 | 26 | -13 | 16 | 1 |
| 31 Mar 23 | 24 | -12 | 16 | 2 |
| 31 Dec 22 | 25 | -9 | 15 | 1 |
| 30 Sep 22 | 23 | -7 | 13 | 1 |
| 30 Jun 22 | 19 | -5 | 12 | 1 |
| 31 Mar 22 | 18 | -3 | 10 | 1 |
| 31 Dec 21 | 16 | -2 | 8 | 1 |
| 30 Sep 21 | 14 | -2 | 8 | 1 |
| 30 Jun 21 | 12 | -2 | 7 | 1 |
| 31 Mar 21 | 10 | -3 | 7 | 1 |
| 31 Dec 20 | 8 | -4 | 7 | 0 |
| 30 Sep 20 | 7 | -2 | 6 | 0 |
| 30 Jun 20 | 7 | -2 | 6 | 0 |
| 31 Mar 20 | 8 | -2 | 6 | 0 |
| 31 Dec 19 | 8 | -2 | 5 | 0 |
| 30 Sep 19 | 9 | -1 | 5 | 0 |
| 30 Jun 19 | 9 | -1 | 5 | 0 |
| 31 Mar 19 | 9 | 0 | 5 | 0 |
| 31 Dec 18 | 8 | 0 | 5 | 0 |
| 31 Dec 17 | 8 | 1 | 3 | 0 |
| 31 Dec 16 | 5 | 0 | 3 | 0 |
Quality Earnings: NSCI is currently unprofitable.
Growing Profit Margin: NSCI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NSCI is unprofitable, and losses have increased over the past 5 years at a rate of 58.1% per year.
Accelerating Growth: Unable to compare NSCI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NSCI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.9%).
Return on Equity
High ROE: NSCI has a negative Return on Equity (-71.48%), as it is currently unprofitable.